Myasthenia Gravis Disease Pharmaceutical and Healthcare Analysis Information
Dec 14, 2018
14th December 2018: MarketResearchFuture announced addition of new report, titled “Myasthenia Gravis Disease Market Research Report - Forecast to 2023”.
Pune, India - December 14, 2018 /MarketersMedia/ —
Regional Analysis
The global myasthenia gravis disease market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas dominates the global myasthenia gravis disease market owing to the growing prevalence of muscular dystrophies such as congenital muscular dystrophies, distal muscular dystrophy, Becker muscular dystrophies, and others along with the extensive demand for diagnostic and treatment services. Moreover, major companies are launching FDA approved drugs thus increasing the commercial access to these drugs worldwide.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5843
The European region is the second largest market for the global myasthenia gravis disease owing to the adoption of new therapies, skilled medical professionals, and availability of advanced treatment facilities. According to the National Institute of Neurological Disorders and Stroke (NINDS), an estimated 15 cases of myasthenia gravis occurs per 100,000 people in the United Kingdom every year.
The Asia Pacific market is the fastest growing therapeutic market owing to the large aging population in countries such as Japan and China coupled with the rising awareness about the long-term effects of muscular dystrophies. Moreover, the cumulative initiatives of the World Health Organization (WHO) in countries such as Japan, China, and India are likely to foster the strengthening of major Asian countries in the future. The Middle East and Africa is likely to exhibit steady growth in this market due to the demand for drugs in remote areas and increasing prevalence of neurological diseases.
Segmentation
The global myasthenia gravis disease market has been segmented on the basis of diagnosis, treatment, and end-user.
On the basis of diagnosis, the global myasthenia gravis disease market can be segmented into imaging, blood tests, electrodiagnostic, edrophonium test, pulmonary function test, and others. The imaging segment is classified into X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and others.
On the basis of treatment, the global myasthenia gravis disease market can be segmented into medication, surgery, autologous Hematopoietic Stem Cell Transplantation (HSCT), plasmapheresis and intravenous immunoglobulin, and others.
The medication segment is divided into acetylcholinesterase inhibitors, immunosuppressant drugs, steroids, and others. The acetylcholinesterase inhibitors are classified into atropine, neostigmine, pyridostigmine, and others. The immunosuppressant drugs are further divided into prednisone, azathioprine, mycophenolate mofetil, tacrolimus, and rituximab. The steroids are further divided into prednisone and others. The surgery is finally divided into thymectomy and others.
On the basis of end-user, the global myasthenia gravis disease market is segmented into hospitals, clinics, academic research institutes, and others.
Key Players
Some of the key players in the global myasthenia gravis disease market are Valeant Pharmaceuticals International (U.S.), Sun Pharmaceuticals Industries Ltd. (India), Piramal Healthcare (India), Novartis Pharmaceuticals Corporation (Switzerland), Apotex Corporation (Canada), Teva Pharmaceutical Industries Ltd. (Israel), RPG Life Sciences (India), Cipla (India), F. Hoffmann Roche La Ltd. (Switzerland), Bristol-Myers Squibb Company (U.S.), Biogen Inc. (U.S.), and AbbVie Inc. (U.S.), GlaxoSmithKline plc (UK), Fresenius Kabi (Germany), and others.
Table of Content: Key Points
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Myasthenia Gravis Disease Market, By Diagnosis
…Continued
Access full report now: https://www.marketresearchfuture.com/reports/myasthenia-gravis-disease-market-5843
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar,
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com
Source: MarketersMedia
Release ID: 460108
More News
New baby bank 'open to everybody'
The facility offers essential items for free, including clothes for babies and small children.
Rising energy costs add to cost of living for Northern Ireland's consumers
Households across Northern Ireland face increasing pressure on the cost of living as energy price hikes have come into effect.
G7 to release millions of barrels of oil and diesel after Trump threat
The co-ordinated release is aimed at heading off further price spikes and avoiding a ban on US diesel exports.
White House Filing Claims President Has Authority to Bar News Outlets
The Trump administration again defended the decision to bar CNN, MS NOW and Politico from the White House and to exclude journalists from the pool that covers the president in small spaces.
Federal Watchdog Investigates Adam Kinzinger for Kalshi Bets on His Pardon
The inquiry by the Commodity Futures Trading Commission centers on bets the former congressman made on Kalshi in the weeks before he was pardoned in January 2025.
US Sanctions A7, a Russia Firm That Helps Sidestep Economic Restrictions
The move followed reports detailing how A7, a Moscow firm, uses shell companies around the world to move funds for clients who are themselves subject to sanctions.
G20 trade ministers meet in Wisconsin amid trade tensions
G20 trade ministers meet in Wisconsin amid trade tensions
Chinese manufacturers dominate Latin America's bus fleet
Chinese manufacturers dominate Latin America's bus fleet
F.D.A. Found Cyclospora During Taylor Farms Inspection in Mexico
The discovery adds strong evidence that the outbreak that sickened thousands over the summer originated in a grower’s field or processing facility.
The Powerful Yet Fragile Force Propping Up Stocks and the Economy
The artificial intelligence boom has pushed up the stock market, even as interest rates have pulled it down, our columnist says.
Mash-Up of Paramount and Warner Bros. Will Be Called Skydance
David Ellison, the tech scion who will run the combined company, borrowed the name of his original entertainment company that reflects his love of aviation. On Friday, the C.E.O.s of Warner Bros. were told they would not stay on once the companies merged.
U.S. and Allies Agree to Release Diesel Reserves as Prices Soar
The Group of 7, which includes Britain, France and Japan, announced the release of 100 million barrels over four months, effective immediately.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.